Insider · CIK 0001600041

Carter Paul Rutherford

Reports to the SEC for 4 companies · GERMANY

sec.gov

Transactions

Companies

Filings

CIK

0001600041

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	IMTXImmatics N.V. · Stock Option (Right to Buy)A Award	Director	AAward	+48K sh	—	—	48,000
2022-06-16	Keenova Therapeutics plcD Disposition to Issuer	Director	DDisposition to Issuer	−20.3K sh	—	—	0
2020-05-13	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−9,117 sh	$2.96	−$27K	20,320
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2019-05-23	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2019-05-15	Keenova Therapeutics plcA Award	Director	AAward	+19.4K sh	—	—	29,437
2019-05-15	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−8,906 sh	$15.21	−$135K	10,041
2018-05-23	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-05-16	Keenova Therapeutics plcA Award	Director	AAward	+18.9K sh	—	—	18,947
2017-05-24	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-08-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−1,817 sh	—	—	4,803
2016-08-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−183 sh	—	—	26,043
2016-08-01	GILDGILEAD SCIENCES, INC.S Sale	EVP Commercial Ops	SSale	−2,000 sh	$79.81	−$160K	62,305
2016-08-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+183 sh	$24.91	+$4,557.615	64,305
2016-08-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+1,817 sh	$40.56	+$73.7K	64,122
2016-07-31	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−2,500 sh	—	—	2,500
2016-07-31	GILDGILEAD SCIENCES, INC.F Tax Payment	EVP Commercial Ops	FTax Payment	−1,317 sh	$79.47	−$105K	62,305
2016-07-31	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+2,500 sh	—	—	63,622
2016-07-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+2,000 sh	$24.91	+$49.8K	63,122
2016-07-01	GILDGILEAD SCIENCES, INC.S Sale	EVP Commercial Ops	SSale	−2,000 sh	$83.12	−$166K	61,122
2016-07-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−2,000 sh	—	—	26,226
2016-06-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+2,000 sh	$24.91	+$49.8K	63,122
2016-06-01	GILDGILEAD SCIENCES, INC.S Sale	EVP Commercial Ops	SSale	−2,000 sh	$87.02	−$174K	61,122
2016-06-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−2,000 sh	—	—	28,226
2016-05-31	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−3,865 sh	—	—	16,906
2016-05-31	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−5,795 sh	—	—	0
2016-05-31	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−4,232 sh	—	—	30,226
2016-05-31	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−43.2K sh	—	—	0
2016-05-31	GILDGILEAD SCIENCES, INC.S Sale	EVP Commercial Ops	SSale	−57.1K sh	$86.85	−$4.96M	61,122
2016-05-31	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+3,865 sh	$80.65	+$312K	118,214
2016-05-31	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+5,795 sh	$80.65	+$467K	114,349
2016-05-31	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+4,232 sh	$24.91	+$105K	108,554
2016-05-31	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+43.2K sh	$24.30	+$1.05M	104,322
2016-05-26	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-05-02	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+183 sh	$24.91	+$4,557.615	63,122
2016-05-02	GILDGILEAD SCIENCES, INC.S Sale	EVP Commercial Ops	SSale	−2,000 sh	$88.72	−$177K	61,122
2016-05-02	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−1,817 sh	—	—	6,620
2016-05-02	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+1,817 sh	$40.56	+$73.7K	62,939
2016-05-02	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−183 sh	—	—	34,458
2016-04-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+2,000 sh	$24.91	+$49.8K	63,122
2016-04-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−2,000 sh	—	—	34,641
2016-04-01	GILDGILEAD SCIENCES, INC.S Sale	EVP Commercial Ops	SSale	−2,000 sh	$91.34	−$183K	61,122
2016-03-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	−2,000 sh	—	—	36,641
2016-03-01	GILDGILEAD SCIENCES, INC.S Sale	EVP Commercial Ops	SSale	−2,000 sh	$87.90	−$176K	61,122
2016-03-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	EVP Commercial Ops	MExercise/Conversion	+2,000 sh	$24.91	+$49.8K	63,122
2016-02-16	GILDGILEAD SCIENCES, INC.F Tax Payment	EVP Commercial Ops	FTax Payment	−7,395 sh	$91.15	−$674K	61,122

Recent filings

Accepted (ET)
Jun 184
Carter Paul Rutherford0000950103-26-009242
SEC(opens sec.gov)
Jun 214
Carter Paul Rutherford0000899243-22-023432
SEC(opens sec.gov)
May 154
Carter Paul Rutherford0000950138-20-000257
SEC(opens sec.gov)
Oct 244
Carter Paul Rutherford0001209191-19-053911
SEC(opens sec.gov)
May 284
Carter Paul Rutherford0001209191-19-033071
SEC(opens sec.gov)
May 174
Carter Paul Rutherford0000950138-19-000308
SEC(opens sec.gov)
May 254
Carter Paul Rutherford0001209191-18-033607
SEC(opens sec.gov)
May 184
Carter Paul Rutherford0000950138-18-000421
SEC(opens sec.gov)
May 264
ALDER BIOPHARMACEUTICALS INC0001209191-17-035976
SEC(opens sec.gov)
Aug 34
GILEAD SCIENCES INC0001127602-16-059414
SEC(opens sec.gov)
Aug 24
GILEAD SCIENCES INC0001127602-16-059283
SEC(opens sec.gov)

Companies

Address

PAUL-EHRLICH-STR. 15

GERMANY, 72076